Member Content

IPO Profile: Certara (CERT) an Intriguing Biopharma Technology Company

by admin | Jan 6, 2021

Certara (CERT) a recent IPO that caught my eye as it is in a similar field as two of my favorites Simulation Plus (SLP) and Schrodinger (SDGR). CERT accelerate medicines to patients using biosimulation software and technology to transform traditional...

Please login to continue reading this article.

Options Hawk Max

$300 | 30 days

Options Hawk Trading Hub Live Chat
Hawk’s Market Blitz
Spotlight Trades (2 Per Week)
Market Recap
Weekly Earnings Snapshots
Live Mock Portfolio
1 on 1 Access
Hawk’s Trader Toolbox
Street Research
OptionsHawk Research
Daily Options Radar
OptionHawk’s Weekly Radar Report
Options Hawk Market Outlook Access
Daily Earnings Grid
Weekly and Monthly OpEx Sheets
Notable Options Database
OptionsHawk Quarterly Market Brief

More About this Plan

Options Hawk Elite

$149 | 30 days

Hawk’s Market Blitz
Spotlight Trades (2 Per Week)
Market Recap
Weekly Earnings Snapshots
OptionsHawk Research
Daily Options Radar
OptionHawk’s Weekly Radar Report
Options Hawk Market Outlook Access
Daily Earnings Grid
OptionsHawk Quarterly Market Brief

More About this Plan